Related Experiment Video
Updated: Mar 8, 2026
12:09
The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo
Published on: June 19, 2014
15.0K
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
Eric P Brown1, Karen G Dowell2, Austin W Boesch1
1Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Journal of Immunological Methods
|February 7, 2017
Summary
Evaluating antibody effector function is crucial for predicting vaccine efficacy. A new high-throughput platform assesses Fc domain characteristics, offering deeper insights into antibody responses and protection against diseases like HIV.
Area of Science:
- Immunology
- Vaccinology
- Biophysics
Background:
- Antibody titers are traditionally used to assess vaccine efficacy but offer a limited view of antibody function.
- Antibody function depends on both antigen-binding (Fv) and effector-mediating (Fc) regions.
- Fc effector function is critical for controlling diseases like HIV and for vaccine-mediated protection.
Purpose of the Study:
- To develop a high-throughput biophysical platform for evaluating Fc domain characteristics of antigen-specific antibodies.
- To gain insights into Fc receptor-mediated antibody effector activity.
- To differentiate between protective and non-protective antibody responses.
Main Methods:
- Development of a novel high-throughput biophysical platform.
- Simultaneous evaluation of multiple dimensions of antibody effector response.
- Analysis of antigen-specific antibodies in polyclonal samples.
Main Results:
- Established a platform for comprehensive antibody effector function assessment.
- Enabled detailed characterization of Fc domain properties.
- Facilitated differentiation of antibody responses based on effector function.
Conclusions:
- The developed platform provides a more complete understanding of antibody responses beyond simple titers.
- Assessing Fc effector function is vital for developing effective vaccines, especially for challenging diseases like HIV.
- This technology can help identify protective immune correlates for novel vaccine candidates.
